Hikma Pharmaceuticals USA: payments to doctors
Reported under the Physician Payments Sunshine Act for Open Payments program years 2019–2025. Figures group every CMS reporting entity belonging to this corporate parent.
- Total reported
- $35.7M
- Providers paid
- 12,375
- Transactions
- 27,280
- Average per transaction
- $1,309
The average per transaction — $1,309 — is the number worth reading. A large total spread across hundreds of thousands of transactions is a company buying a great many modest meals at educational presentations. A large total across few transactions means consulting, speaking or royalty arrangements with a small number of physicians. The totals alone do not distinguish them.
Where the money went
| State | Total reported | Share |
|---|---|---|
| Texas | $13,501,370 | 37.8% |
| Florida | $5,260,431 | 14.7% |
| California | $4,477,113 | 12.5% |
| North Carolina | $1,275,112 | 3.6% |
| Ohio | $1,250,588 | 3.5% |
| New Jersey | $939,591 | 2.6% |
| New York | $910,832 | 2.5% |
| Missouri | $817,467 | 2.3% |
| Oregon | $792,859 | 2.2% |
| Oklahoma | $782,903 | 2.2% |
| Arizona | $543,110 | 1.5% |
| Massachusetts | $446,360 | 1.2% |
| District of Columbia | $440,657 | 1.2% |
| Nevada | $410,533 | 1.1% |
| Colorado | $371,819 | 1.0% |
| Maryland | $362,818 | 1.0% |
| Alabama | $344,720 | 1.0% |
| Pennsylvania | $321,787 | 0.9% |
| South Carolina | $304,499 | 0.9% |
| Arkansas | $303,274 | 0.8% |
| Nebraska | $283,810 | 0.8% |
| Wisconsin | $246,507 | 0.7% |
| Virginia | $217,330 | 0.6% |
| Rhode Island | $182,786 | 0.5% |
| Montana | $130,569 | 0.4% |
| Georgia | $130,333 | 0.4% |
| Tennessee | $106,451 | 0.3% |
| Connecticut | $88,972 | 0.2% |
| Louisiana | $77,998 | 0.2% |
| Kentucky | $73,848 | 0.2% |
| Mississippi | $47,776 | 0.1% |
| Utah | $47,443 | 0.1% |
| West Virginia | $40,886 | 0.1% |
| Illinois | $39,835 | 0.1% |
| Michigan | $39,537 | 0.1% |
| Maine | $26,724 | 0.1% |
| South Dakota | $21,203 | 0.1% |
| Idaho | $20,158 | 0.1% |
| Indiana | $10,769 | 0.0% |
| Minnesota | $10,170 | 0.0% |
| New Hampshire | $6,157 | 0.0% |
| ZZ | $4,000 | 0.0% |
| Washington | $2,327 | 0.0% |
| Puerto Rico | $2,070 | 0.0% |
| Kansas | $1,475 | 0.0% |
| Delaware | $586 | 0.0% |
| Wyoming | $566 | 0.0% |
| New Mexico | $327 | 0.0% |
| Iowa | $290 | 0.0% |
| Hawaii | $81 | 0.0% |
| Alaska | $78 | 0.0% |
| Vermont | $21 | 0.0% |
Products named in Hikma Pharmaceuticals USA's payments
The drugs and devices most often named as the product a payment related to. A meal at a presentation about a product counts here, so this tracks what the company promotes as much as what it sells.
- OXYCODONE HYDROCHLORIDE$1,248,969
- MORPHINE SULFATE$1,247,847
- OXYMORPHONE HYDROCHLORIDE$1,247,847
- BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE$544,526
- Buprenorphine HCL$544,526
- Buprenorphine & Naloxone$409,223
- Buprenorphine$409,223
- Ryaltris$285,041
- VALRUBICIN INTRAVESICAL SOLUTION$247,608
- Dasatinib$198,775
- Kloxxado$197,774
- Ibrutinib$196,300
- Mitigare$173,455
- Abiraterone$159,609
- Lenalidomide$149,093